Benfotiamine and Long-Chain Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Treatment of Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus
Journal Title: Lviv Clinical Bulletin - Year 2013, Vol 3, Issue 3
Abstract
Introduction. The cardiovascular form of diabetic autonomic neuropathy (DANP) in patients with type 2 diabetes mellitus (DM), is characterized by the damage of the nerve fibers of the parasympathetic and sympathetic parts of the autonomic nervous system, and is considered to be one of the main causes of cardiac arrhythmias, an independent risk factor of cardiovascular mortality. Therefore, the problem of prevention and treatment of DANP is especially relevant. The pathogenetic treatment of DANP includes rational nutrition and physical activity, optimization of glycemic control, treatment of dyslipoproteinemia (DLP), correction of metabolic disorders of the myocardium, prevention and treatment of thrombosis, use of aldose reductase inhibitors, γ-linolenic acid, acetyl-L-carnitine, antioxidants, in particular α-lipoic acid (α-LA), long-chain ω-3 and ω-6 polyunsaturated higher fatty acids, vasodilators, fat-soluble vitamin B1, aminoguanidine, substitution treatment with myoinozitol, growth factors, etc. Aim. To evaluate the efficacy of treatment with benfotiamine, long-chain ω-3 and ω-6 polyunsaturated higher fatty acids of the cardiovascular form of diabetic autonomic neuropathy in patients with type II DM. Materials and methods. Тhe study involved 59 patients with type 2 diabetes mellitus (DM) and cardiovascular autonomic neuropathy (CAN), aged 50–59 years, with a disease duration of 1–6 years and HbA1c index (7.1 ± 0.6 %). Patients with type 2 DM and CAN were allocated to four treatment groups: patients of the 1st group received traditional hypoglycemic therapy (n=15); to patients from the 2nd group (n = 21), in addition to the standard treatment, was prescribed 1 capsule of “Omacor®” daily; to the 3rd group of patients (n = 12) – benfotiamine 300.0 mg per day; to the 4th group (n = 11) – “Omacor®” (1 capsule/day) in combination with benfotiamine 300.0 mg per day. Results. It has been established, that combined prescription of “Omacor ®” and benfotiamine is accompanied by more significant positive changes in HDL, triglycerides and leptin levels comparing to control group and group treated with benfotiamine, but no statistically significant changes compared to the therapy with “Omacor®” have been obtained. Application of this combination was accompanied by more significant positive changes in IRI, hsCRP and TNF-α levels compared to other groups. Conclusions. The efficacy of combined therapy with “Omacor®” and benfotiamine is not determined by the improved compensation of type 2 DM, but is the result of direct effect of pharmacological agents on the investigated metabolic parameters.
Authors and Affiliations
V. Serhiyenko, O. Serhiyenko
Keywords
Related Articles
- EP ID EP257322
- DOI 10.25040/lkv2013.03.008
- Views 105
- Downloads 0
Эффективность L-аргинина и L-карнитина в составе комплексного лечения больных острым инфарктом миокарда с коморбидным метаболическим синдромом
Введение. Важное значение в патогенезе атеросклероза, ишемической болезни сердца и инфаркта миокарда (ИМ) в частности имеет синергическое влияние различных компонентов метаболического синдрома (МС), которые формируют ряд...
The Effectiveness of Treatment of the Duodenum Peptic Ulcer in the Lviv Region (Retrospective Analysis)
Introduction. The prevalence of H. pylori infection has declined in recent years. However, the processes of population migration offset this difference, and the decline in the rate of distribution of H. pylori has recen...
Аналіз взаємозв’язків маркерів кісткового ремоделювання та індексу активності системного червоного вовчака
Вступ. Системний червоний вовчак (СЧВ) – системна автоімунна хвороба, яка характеризується мультиорґанними ураженнями, зокрема кісток. Виникнення остеопорозу (ОП) – тривалий процес, і навіть важке загострення не має до...
Структурно-функциональные изменения миокарда при коморбидности постинфарктного кардиосклероза и сахарного диабета 2-го типа
Введение. Заболевания ишемической болезнью сердца (ИБС) и сахарным диабетом (СД) встречаются часто и распространенность их постоянно растет. Цель. Оценить параметры геометрии левого желудочка (ЛЖ) у больных с постинфаркт...
Сoronary Artery Anomalies: the Efficiency in Diagnosis by the Improved Method in Autopsy Material
Introduction. Coronary arteries anomalies can only be found during the pathomorphololgical detailed study because clinical symptoms are often absent. The coronary artery anomalies are classified as anomalies of originati...